FAM
PCRX icon

Fortaleza Asset Management’s Pacira BioSciences PCRX Stock Holding History

Fortaleza Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,470
Closed -$104K – 201
2015
Q2 		$104K Sell
1,470
-2,475
-63% -$195K 0.06% 144
2015
Q1 		$351K Sell
3,945
-2,910
-42% -$295K 0.2% 95
2014
Q4 		$608K Buy
6,855
+150
+2% +$14.2K 0.28% 132
2014
Q3 		$650K Buy
+6,705
New +$652K 0.31% 131

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fortaleza Asset Management's PCRX Position: Q3 2015 in Review

Fortaleza Asset Management sold out of Pacira BioSciences (PCRX) in Q3 2015, closing a stake of 1,470 shares — an estimated $104K sold.

Fortaleza Asset Management first reported a position in PCRX in Q3 2014 and held it in 4 quarters. The position peaked at $650K in Q3 2014. 177 funds tracked by Wall St. Rank hold PCRX as of Q3 2015.

  • Fortaleza Asset Management reported no remaining Pacira BioSciences position as of Q3 2015 after selling out during the quarter.
  • Fortaleza Asset Management sold 1,470 Pacira BioSciences shares in Q3 2015, an estimated $104K.
  • Fortaleza Asset Management first reported a position in Pacira BioSciences in Q3 2014 and held it in 4 quarters.
  • Fortaleza Asset Management's Pacira BioSciences position peaked at $650K in Q3 2014.
  • 177 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2015.

Based on Fortaleza Asset Management's 13F filing for Q3 2015, filed 22 Oct 2015.